<DOC>
	<DOCNO>NCT01123031</DOCNO>
	<brief_summary>A bleeding peptic ulcer remain serious medical problem significant morbidity mortality . Endoscopic therapy significantly reduce bleeding , surgery , mortality patient bleed peptic ulcer recommend first hemostatic modality patient . In past year , adjuvant use high-dose proton pump inhibitor ( PPI ) endoscopic therapy endorse study . Laine Javid et al find oral PPI IV PPI similar intragastric pH response past two year . Therefore , whether oral replace IV management peptic ulcer bleed objective study . The investigator enrol 130 patient active bleed nonbleeding visible vessels（NBVV） study . They randomly assign oral lansoprazole IV nexium group . All patient receive successful endoscopic therapy heater probe hemoclip placement . In lansoprazole group ( N=65 ) , 30 mg four time daily give orally three day . Thereafter , patient receive 30 mg lansoprazole orally daily two month . In nexium group , 160 mg/day continuous infusion give three day . Thereafter , patient receive 40 mg nexium orally daily two month . The primary end point recurrent bleed discharge within 14 day . At day 14 , volume blood transfuse , number surgery perform , mortality rate two group compare well .</brief_summary>
	<brief_title>Oral v Intravenous Proton Pump Inhibitor ( PPI）for Peptic Ulcer Bleeding ( PUB )</brief_title>
	<detailed_description>A bleeding peptic ulcer remain serious medical problem significant morbidity mortality . Endoscopic therapy significantly reduce bleeding , surgery , mortality patient bleed peptic ulcer ( 1 ) recommend first hemostatic modality patient ( 1 , 2 ) . In past year , adjuvant use high-dose proton pump inhibitor ( PPI ) endoscopic therapy endorsed study , two consensus statement two meta-analysis ( 3-8 ) . To sustain high intragastric pH , high dose omeprazole use previous study concern high-risk peptic ulcer bleeding . In study , investigator use 40 mg omeprazole intravenous bolus follow 160 mg/day continuously infusion three day . The mean intragastric pH rise 6.0 one hour initial bolus omeprazole omeprazole group ; persist around value rest 24 hours.7 The rebleeding rate much low PPI compare H2RA group ( Day 3 : 0/50 v 8/50 , p &lt; 0.01 ; Day 14 : 2/50 v 12/50 , p &lt; 0.01 ) ( 4 ) . How route PPI usage ? Oral IV prefer route ? Laine et al use oral lansoprazole patient peptic ulcer bleeding.9 They randomly assign intravenous lansoprazole ( 90-mg bolus follow 9-mg/h infusion ) oral lansoprazole ( 120-mg bolus follow 30 mg every 3 hour ) . A pH record 24 hour . Mean pH rise 6 2-3 hour intravenous PPI 3-4 hour oral PPI . They conclude frequent oral PPI may able replace currently recommend intravenous bolus plus infusion PPI therapy patient bleed ulcer . In one recent article , Javid et al also prove significant difference among various PPIs ( omeprazole , pantoprazole , rabeprazole ) give different route ( IV oral route ) raise intragastric pH 6 72 h successful endoscopic hemostasis bleed peptic ulcer.10 In recent study , investigator prove oral rabeprazole IV omeprazole equally effective prevent rebleeding ( 13/78 rabeprazole v 12/78 omeprazole , p &gt; 0.1 ) high-risk bleed peptic ulcers.11 All secondary outcome two group similar , include amount blood transfusion , hospital stay , need surgery mortality . The objective study assess outcomes two different regimen oral lansoprazole v high dose intravenous nexium endoscopic therapy patient peptic ulcer bleeding .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>A peptic ulcer active bleeding , nonbleeding visible vessel ( NBVV ) adherent blood clot ulcer base observe within 24 hour hospital admission Patients exclude study pregnant , Do obtain initial hemostasis endoscopic injection epinephrine Do give write informed consent Have bleeding tendency ( platelet count &lt; 50×109/L , serum prothrombin &lt; 30 % normal , take anticoagulant ) Uremia .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>